CHILTON INVESTMENT CO INC.

Position in NVS — Novartis AG

CIK 1332632 STAMFORD, CT

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$352,620

+$8,933 QoQ

Shares Held

2,250

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,048

of 1,603 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHILTON INVESTMENT CO INC. holds $21,642,442 across 10 Drug Manufacturers - General names. NVS ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,720	$6,860,740
2	JNJ	Johnson & Johnson	20,745	$5,268,607
3	ABBV	AbbVie Inc.	16,964	$4,268,820
4	MRK	Merck & Co., Inc.	13,953	$1,792,960
5	AMGN	Amgen Inc	3,302	$1,195,720
6	AZN	Astrazeneca PLC	5,268	$998,918
7	BMY	Bristol Myers Squibb Co	7,562	$435,722
8	NVS	Novartis AG This page	2,250	$352,620

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$352,620	2,250	0.0%	Shares	Sole	2026-08-14
2026-03-31	$343,687	2,250	-56.3%	Shares	Sole	2026-05-15
2025-12-31	$709,616	5,147	0.0%	Shares	Sole	2026-02-17
2025-09-30	$660,051	5,147	+128.8%	Shares	Sole	2025-11-14
2025-06-30	$272,272	2,250	+4.7%	Shares	Sole	2025-08-14
2025-03-31	$239,682	2,150	0.0%	Shares	Sole	2025-05-15
2024-12-31	$209,216	2,150	-6.5%	Shares	Sole	2025-02-14
2024-09-30	$264,546	2,300	0.0%	Shares	Sole	2024-11-14
2024-06-30	$244,858	2,300	0.0%	Shares	Sole	2024-08-14
2024-03-31	$222,479	2,300	0.0%	Shares	Sole	2024-05-15
2023-12-31	$232,231	2,300	-2.6%	Shares	Sole	2024-02-14
2023-09-30	$240,491	2,361	0.0%	Shares	Sole	2023-11-14
2023-06-30	$238,248	2,361	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.